New Vitalis, LLC dba New Vitalis Pharmacy
FDA warning letter issued 2022-05-18 · posted 2022-05-31
Letter details
- Company
- New Vitalis, LLC dba New Vitalis Pharmacy
- Subject
- Compounding Pharmacy/Adulterated Drug Products
- Issuing office
- Division of Pharmaceutical Quality Operations III
- Letter issue date
- 2022-05-18
- Posted date
- 2022-05-31
- Case number
- 633440
Read the full letter on fda.gov
FDA's public listing keeps roughly five years of letters; older ones roll off. Atlas preserves every letter it has ingested since September 2026 and refreshes the listing weekly. Verify enforcement matters against the primary source linked above.
Hear about the next one
Watch an issuing office from its directory page and new letters land in your change alerts. Elsewhere this data sells for hundreds of dollars per document; here it is part of the record.